Nonalcoholic Fatty Liver Disease: A Spectrum of Disorders — Podcast

https://annals.org/aim/fullarticle/2727257/annals-call-nonalcoholic-fatty-liver-disease-spectrum-disorders

Audio. Annals On Call – Nonalcoholic Fatty Liver Disease: A Spectrum of Disorders: Dr. Centor discusses nonalcoholic fatty Liver disease with Dr. Meagan Gray, Assistant Professor of Medicine, University of Alabama.

 

Advertisements

A1c test MISSES Many Cases of Diabetes

Must read if you’re an underwriter.  Here.

The new study included 9,000 adults without a diabetes diagnosis. The participants got both an A1c test and an oral tolerance glucose test, and the researchers compared the results. The researchers found the A1c test didn’t catch 73 percent of diabetes cases that were detected by the oral glucose test. “The A1c test said these people had normal glucose levels when they didn’t,” Chang Villacreses said.

HgA1C and the Prediction of DM2

RESULTS – During long-term follow-up of children and adolescents who did not initially have diabetes, the incidence rate of subsequent diabetes was fourfold (in boys) as high and more than sevenfold (in girls) as high in those with HbA1c ≥5.7% as in those with HbA1c ≤5.3%—greater rate ratios than experienced by adults in the same HbA1c categories. Analyses of ROCs revealed no significant differences between HbA1c, FPG, and 2hPG in sensitivity and specificity for identifying children and adolescents who later developed diabetes. CONCLUSIONS – HbA1c is a useful predictor of diabetes risk in children and can be used to identify prediabetes in children with other type 2 diabetes risk factors with the same predictive value as FPG and 2hPG.

Source: Diabetes Care

Opioid Abuse & Mortality Trends – Physician’s Weekly for Medical News, Journals & Articles

Physician’s Weekly provides news & information online and at the point-of-care to hospitals, oncology centers & physician group practices, including specialty editions for Surgery, Emergency Departments, Oncology & Primary Care.

Source: CME: Opioid Abuse & Mortality Trends | Physician’s Weekly for Medical News, Journals & Articles

Will someone please explain to me why as an industry we continue to test life insurance applicants for cocaine but choose to ignore other drugs of abuse?